Literature DB >> 28695463

Effects of exercise training on anabolic and catabolic markers in patients with chronic heart failure: a systematic review.

Chien-Tzu Lee1, Ling-Wei Chen1, Meng-Yueh Chien2,3.   

Abstract

Decreased anabolism because of alterations in the insulin-like growth factor 1 (IGF-1)/growth hormone (GH) axis and increased catabolism induced by proinflammatory cytokines like tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) have been reported to contribute to muscle wasting in chronic heart failure (CHF). However, it is unclear whether exercise training could modulate anabolic and catabolic markers in CHF patients. The purpose of this study was to investigate the effects of exercise intervention on anabolic and catabolic markers for patients with CHF. Literatures were systematically searched in electronic databases and relevant references. Only published randomized controlled trials (RCTs) focusing on exercise training for CHF were eligible for inclusion. Outcome measurements included serum level and muscle biopsy of TNF-α, IL-6, GH, and IGF-I. Of the six included studies, four showed no significant difference between exercise group and control group in the serum levels of TNF-α, IL-6, GH, and IGF-I. However, two studies showed significant reduction in TNF-α and IL-6 and increase in IGF-I by local skeletal muscle biopsy. We conclude that the decreases in catabolic markers and increases in anabolic after exercise training were evident only by local skeletal muscle biopsy. More RCTs on dose-response relation of exercise programs are needed to further optimize anabolic and anti-inflammatory benefits of exercise training in patients with CHF.

Entities:  

Keywords:  Anabolism; Catabolism; Chronic heart failure; Exercise; Pro-inflammatory markers

Mesh:

Substances:

Year:  2017        PMID: 28695463     DOI: 10.1007/s10741-017-9639-y

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  30 in total

1.  Reliability of the PEDro scale for rating quality of randomized controlled trials.

Authors:  Christopher G Maher; Catherine Sherrington; Robert D Herbert; Anne M Moseley; Mark Elkins
Journal:  Phys Ther       Date:  2003-08

2.  Inflammatory mediators in chronic heart failure: an overview.

Authors:  Stefan D Anker; Stephan von Haehling
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

3.  The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study.

Authors:  Natalie A de Morton
Journal:  Aust J Physiother       Date:  2009

4.  Skeletal muscle atrophy and peak oxygen consumption in heart failure.

Authors:  M J Toth; S S Gottlieb; M L Fisher; E T Poehlman
Journal:  Am J Cardiol       Date:  1997-05-01       Impact factor: 2.778

Review 5.  Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.

Authors:  Masakazu Saitoh; Junichi Ishida; Wolfram Doehner; Stephan von Haehling; Markus S Anker; Andrew J S Coats; Stefan D Anker; Jochen Springer
Journal:  Int J Cardiol       Date:  2017-04-01       Impact factor: 4.164

6.  Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure.

Authors:  L Gullestad; H Aass; J G Fjeld; L Wikeby; A K Andreassen; H Ihlen; S Simonsen; J Kjekshus; S Nitter-Hauge; T Ueland; E Lien; S S Frøland; P Aukrust
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

7.  Effects of different training modalities on circulating anabolic/catabolic markers in chronic heart failure.

Authors:  Patrick Feiereisen; Michel Vaillant; Georges Gilson; Charles Delagardelle
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Sep-Oct       Impact factor: 2.081

8.  Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance.

Authors:  J R Minotti; I Christoph; R Oka; M W Weiner; L Wells; B M Massie
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

9.  Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients.

Authors:  Luisa Ribeiro de Meirelles; Cristiane Matsuura; Angela de Castro Resende; Angelo Antunes Salgado; Natália Rodrigues Pereira; Pedro Guimaraes Coscarelli; Antônio C Mendes-Ribeiro; Tatiana M C Brunini
Journal:  Eur J Prev Cardiol       Date:  2013-05-21       Impact factor: 7.804

10.  Abnormalities of skeletal muscle in patients with chronic heart failure.

Authors:  D P Lipkin; D A Jones; J M Round; P A Poole-Wilson
Journal:  Int J Cardiol       Date:  1988-02       Impact factor: 4.164

View more
  4 in total

1.  Effect of aerobic and resistance training on inflammatory markers in heart failure patients: systematic review and meta-analysis.

Authors:  M J Pearson; S F Mungovan; N A Smart
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

2.  High Intensity Interval Training Leads to Similar Inflammatory Activation as Seen With Traditional Training in Chronic Heart Failure.

Authors:  Arlana G Taylor; Andrew I Ignaszewski; Shannon S D Bredin; John S Hill; Erin M Shellington; Darren E R Warburton
Journal:  Front Cardiovasc Med       Date:  2022-02-08

3.  Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways.

Authors:  Xiaowen Wang; Kaiyun Yan; Cuifeng Wen; Jiaqi Wang
Journal:  Cardiovasc Ther       Date:  2022-03-12       Impact factor: 3.023

Review 4.  Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?

Authors:  Przemyslaw J Kotyla
Journal:  Int J Mol Sci       Date:  2018-06-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.